Soy infant formula and phytoestrogens

Journal of Paediatrics and Child Health

Volumn 39, Issue 6, 2003, Pages 401-405

  Tuohy, P G ^a  

^a MINISTRY OF HEALTH   (New Zealand)

Author keywords

Daidzein; Genistein; Isoflavone; Phytoestrogen; Soy infant formula

Indexed keywords

DAIDZEIN; ESTROGEN; GENISTEIN; ISOFLAVONE; PHYTOESTROGEN;

ANTINEOPLASTIC ACTIVITY; ARTIFICIAL MILK; BREAST CANCER; CANCER PREVENTION; CARCINOGENESIS; FOOD COMPOSITION; HUMAN; IMMUNE SYSTEM; NONHUMAN; PRIORITY JOURNAL; REPRODUCTION; REVIEW; RISK BENEFIT ANALYSIS; SOYBEAN; THYROID CANCER; THYROID DISEASE; UTERUS CANCER;

ENDOCRINE GLANDS; HUMANS; INFANT; INFANT FORMULA; NEOPLASMS; PHYTOESTROGENS; REPRODUCTION; RISK ASSESSMENT; SOY FOODS;

EID: 0141613919     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1754.2003.00178.x     Document Type: Review

References (56)

1. Bern HA. The fragile fetus. In: Colbern T, Clement C, eds. Chemically Induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection. Scientific Publishing, Princeton, NJ, 1992; 9-15.
2. Irvine HG, Fitzpatrick MG, Alexander SL. Phytoestrogens in soybased infant foods: concentrations, daily intake and possible biological effects. Proc. Soc. Exp. Biol. Med. 1998; 217: 247-53.
3. Sharpe RM, Martin B, Morris K et al. Infant feeding with soy formula milk: effects on the testis and on blood testosteone levels in marmoset monkeys during the period of neonatal testicular activity. Hum. Reprod. 2002; 17: 1692-703.
4. Newbold RR. Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens. Environ. Health Perspect. 1995; 103: 83-7.
5. Ashby J. The Gerhard Zbinden memorial lecture: are environmental chemicals affecting the integrity or expression of the human genome. Toxicol. Lett. 2000; 112-113: 3-8.
6. Coldham NG, Dave M, Sivapathasundraham S et al. Evaluation of a recombinant yeast cell estrogen screening Assay. Environ. Health Perspect. 1997; 105: 734-42.
7. O'Connor JC, Frame SR, Biegel LB, Cook JC, Davis LG. Sensitivity of a Tier 1 screening battery compared to an in utero exposure for detecting the estrogen receptor agonist 17 beta-estradiol. Toxicol. Sci. 1998; 44: 169-84.
8. Kuiper G, Enmark E, Pelto-Huikko M, Nilsson S, Gufstasson J-A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl Acad. Sci. 1996; 93: 5925-30.
9. Casanova M, You L, Gaido K, Archibeque-Engle S, Janszen DB, Heck HA. Developmental effects of dietary phytoestrogens in Sprague-Dawley rats and interactions of genistein and daidzein with rat oestrogen receptors alpha and beta in vitro. Toxicol. Sci. 1999; 51: 236-44.
10. Knight DC, Eden JA, Huang JC, Wariz MA. Isoflavine content of infant foods and formulas. J. Paediatr. Child Health 1998; 34: 135-8.
11. Taylor GJ, Burlingame BA. Phytoestrogens in Selected NZ Foods. FoodInfo Confidential Report no. 241. Crop & Food Research, Christchurch, 1998.
12. Setchell KDR, Zimmer-Nechemiah L, Cai J, Huebi JE. Isoflavone content of infant formula and the metabolic fate of those phytoestrogens in early life. Am. J. Clin. Nutr. 1998; 68 (Suppl.): 1453-61.
13. Kurzer MS, Xu X. Dietary phytoestrogens. Ann. Rev. Nutr. 1997; 17: 353-81.
14. Setchell KDR, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J. Nutr. 1999; 129: 758S-767S.
15. Newbold RR, Padilla Banks E, Bullock B, Jefferson WN. Uterine adenocarcinoma in mice treated neonatally with genistein. Cancer Res. 2001; 61: 4325-8.
16. Hilakivi-Clarke L, Cho E, Clarke R. Maternal genistein exposure mimics the effects of estrogen on mammary gland development in female mouse offspring. Oncol. Report 1998; 5: 609-16.
17. Hilakivi-Clarke L, Cho E, Onojafe I, Raygada M, Clarke R. Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring. Oncol. Report 1999; 6: 1089-95.
18. Innes K, Byers T, Schymura M. Birth characteristics and subsequent risk for breast cancer in very young women. JNCI 1997; 89: 71-6.
19. Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phytoestrogens and breast cancer. Lancet 1997; 350: 990-4.
20. Hilakivi-Clarke L, Onojafe I, Raygada M et al. Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br. J. Cancer 1999; 80: 1682-8.
21. Newcomb PA, Storer BE, Longnecker MP et al. Lactation and a reduced risk of premenopausal breast cancer. N. Engl. J. Med. 1994; 330: 81-7.
22. Yang J, Nakagawa H, Tsuta K, Tsubura A. Influence of perinatal genistein exposure on the development of MNU-induced mammary carcinoma in female Sprague-Dawley rats. Cancer Lett. 2000; 149: 171-9.
23. Young HJ, Alfred CD, Alfred KF, Karko KL, Doerge DR, Helferich WG. physiological concentrations of dietary genistein dose-dependantly stimulate growth of estrogen-dependant human breast cancer (MCF-7) tumors implanted in athymic nude mice. J. Nutr. 2001; 131: 2957-62.
24. Cappen CC. Toxic responses of the endocrine system. In: Klassen CD, ed. Casarett and Doull's Toxicology: The Basic Science of Poisons, 6th edn. McGraw Hill, New York, 2001.
25. Kimura S, Suwa J, Ito M, Sato H. Development of malignant goiter by defatted soybean with iodine-free diet in rats. Gann 1976; 67: 763-5.
26. Son H-Y, Nishikawa A, Ikeda T et al. Lack of modifying effects of environmental estrogenic compounds on the development of thyroid proliferative lesions in male rats pretreated with DHPN. Jpn. J. Cancer Res. 2000; 91: 899-905.
27. Hirzel S. Genistein: model substance for describing endocrine effects of phytoestrogrns. BUA Report 222. German Chemical Society - Advisory Committee on Existing Chemicals, Stuttgart, 2000.
28. Gordon JE, Harris G, Fiegert M, McElduff A. Iodine deficiency in ambulatory participants at a Sydney teaching hospital: is Australia truly iodine replete? Med. J. Aust. 1999; 171: 467-70.
29. Skeaff SA, Thmpson CD, Gibson RS. Mild iodine deficiency in a sample of New Zealand schoolchildren. Eur. J. Clin. Nutr. 2002; 56: 1169-75.
30. Fitzpatrick M. Soy formulas and the effects of isoflavones on the thyroid. NZ Med. J. 2000; 113: 24-6.
31. Fort P, Moses N, Fasano M, Goldberg T, Lifshitz F. Breast and soy-formula feedings in early infancy and the prevalence of autoimmune thyroid disease in children. J. Am. Coll. Nutr. 1990; 9: 164-7.
32. Lindbergh B, Ericsson U-B, Fredriksson B et al. The coexistence of thyroid autoimmunity in chldren and adolescents with various allergic diseases. Acta Paediatr. 1998; 87: 371-4.
33. Van Middlesworth L. Thyroxine excretion, possible cause of goiter. Endocrinology 1957; 61: 570-3.
34. Divi RL, Chang HC, Doerge DR. Anti-thyroid isoflavones from soybean. Biochem. Pharmacol. 1997; 54: 1087-96.
35. Chang HC, Doerge DR. Dietary genistein inactivates rat thyroid peroxidase in vivo without an apparent hypothyroid effect. Toxicol. Appl. Pharmacol. 2000; 168: 244-52.
36. Doerge DR, Chang HC. Inactivation of thyroid peroxidase by soy isoflavones, in vitro and in vivo. J. ChromotogrB 2002; 777: 269-79.
37. Santell RC, Chang YC, Nair MG, Helferich WG. Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/ pituitary axis in rats. J. Nutr. 1997; 127: 263-9.
38. Cassidy A, Bingham S. Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products. Br. J. Nutr. 1995; 74: 587-601.
39. Cassidy A, Bingham S, Setchell KDR. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of pre-menopausal women. Am. J. Clin. Nutr. 1994; 60: 333-40.
40. Strom BL, Schinnar R, Zeigler EE et al. Exposure to soy-based formula in infancy and endocrinological and reproductive outcomes in young adulthood. JAMA 2001; 286: 807-14.
41. Goldman LR, Newbold R, Swan SH. Exposure to soy-based formula Infancy (Letter). JAMA 2001; 286: 2402.
42. Kumi-Diaka J, Nguyen V, Butler A. Cytotoxic potential of the phytochemical genistein isofiavone (4′, 5′, 7-trihydroxyisoflavone) and certain environmental chemical compounds on testicular cells. Biol. Cell 1999; 91: 515-23.
43. Herman-Giddens ME, Slora EJ, Wasserman RC et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Paediatric Research in Office Settings Network. Pediatrics 1997; 99: 505-12.
44. McKinney JD, Waller CL. Polychlorinated biphenyls as hormonally active structural analogues. Environ. Health Perspect. 1994; 102: 290-7.
45. Australian College of Paediatrics. Position statement: soy protein formula. J. Paediatr. Child Health 1998; 34: 318-9.
46. American Academy of Paediatrics. Soy protein based formulas: recommendations for use in infant feeding (RE9806). Available from: http://www.aap.org/policy/re9806.html.
47. Aggett PJ, Agostini C, Gouter O. Medical position paper. The nutritional and safety assessment of breast milk substitutes and other dietary products for infants: a commentary by the ESPGHAN Committee for Nutrition. JPGN 2001; 32: 256-8.
48. Paediatric Society of Canada. Position statement. Available from URL: http://www.hc-sc.gc.ca/hppb/childhood-youth/cyfh/homepage/nutrition/index.html.
49. New Zealand Ministry of Health. Soy based infant formula. Available from URL: http://www.moh.govt.nz.
50. UK Food Standards Agency. Consultation on the Committee on Toxicology Report on Phytoestrogens and Health. Available from URL: http//http://www.food.gov.uk/news/newsarchive/phytoestrogen_draff-report.
51. Zimmerli B, Schlatter J. Occurrence and significance of the isoflavones daidzein and genistein in infant formulas. Federal Office of Health. Food Research Section, Bern, 1997; (in German).
52. Australian and New Zealand Food Authority. Phytoestrogens. An assessment of the potential risks to infants associated with exposure to soy based formula. ANZFA, Canberra, 1999.
53. An J, Tzagarakis-Foster C, Scharschmidt TC et al. Estrogen receptor β-selective transcriptional activity and recruitment of co-regulators by phytoestrogens. JBC 2001; 276: 17808-14.
54. McDonnell DP, Norris JD. Connections and regulation of the human estrogen receptor. Science 2002; 296: 1642-4.
55. Wagner CK, Pfau JL, De Vries GJ, Merchenthaler IJ. Sex differences in progesterone receptor immunoreactivity in neonatal mouse brain depend on estrogen receptor alpha expression. J. Neurobiol. 2001; 47: 176-82.
56. Takeyama J, Suzuki T, Inou S et al. Expression and cellular localisation of estrogen receptors α and β in the human fetus J. Clin. Endocrinol. Metab 2001; 86: 2258-62.